MCK Quote, Financials, Valuation and Earnings

Cardinal Health, Inc. has a net margin of 1.18% compared to McKesson Corp.'s net margin of 0.72%. McKesson Corp.'s return on equity of -- beat Cardinal Health, Inc.'s return on equity of --.

McKesson Corp. has a consensus price target of $980.40, signalling upside risk potential of 3.48%. On the other hand Cardinal Health, Inc. has an analysts' consensus of $247.80 which suggests that it could grow by 10.41%. Given that Cardinal Health, Inc. has higher upside potential than McKesson Corp., analysts believe Cardinal Health, Inc. is more attractive than McKesson Corp..

McKesson Corp. has a beta of 0.405, which suggesting that the stock is 59.521% less volatile than S&P 500. In comparison Cardinal Health, Inc. has a beta of 0.642, suggesting its less volatile than the S&P 500 by 35.798%.

McKesson Corp. has a quarterly dividend of $0.82 per share corresponding to a yield of 0.32%. Cardinal Health, Inc. offers a yield of 0.91% to investors and pays a quarterly dividend of $0.51 per share. McKesson Corp. pays 10.69% of its earnings as a dividend. Cardinal Health, Inc. pays out 31.43% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson Corp. quarterly revenues are $106.2B, which are larger than Cardinal Health, Inc. quarterly revenues of $65.6B. McKesson Corp.'s net income of $1.3B is higher than Cardinal Health, Inc.'s net income of $471M. Notably, McKesson Corp.'s price-to-earnings ratio is 27.25x while Cardinal Health, Inc.'s PE ratio is 32.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson Corp. is 0.30x versus 0.22x for Cardinal Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Cencora, Inc. has a net margin of 1.18% compared to McKesson Corp.'s net margin of 0.66%. McKesson Corp.'s return on equity of -- beat Cencora, Inc.'s return on equity of 107.99%.

McKesson Corp. has a consensus price target of $980.40, signalling upside risk potential of 3.48%. On the other hand Cencora, Inc. has an analysts' consensus of $403.79 which suggests that it could grow by 11.83%. Given that Cencora, Inc. has higher upside potential than McKesson Corp., analysts believe Cencora, Inc. is more attractive than McKesson Corp..

McKesson Corp. has a beta of 0.405, which suggesting that the stock is 59.521% less volatile than S&P 500. In comparison Cencora, Inc. has a beta of 0.676, suggesting its less volatile than the S&P 500 by 32.374%.

McKesson Corp. has a quarterly dividend of $0.82 per share corresponding to a yield of 0.32%. Cencora, Inc. offers a yield of 0.64% to investors and pays a quarterly dividend of $0.60 per share. McKesson Corp. pays 10.69% of its earnings as a dividend. Cencora, Inc. pays out 27.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson Corp. quarterly revenues are $106.2B, which are larger than Cencora, Inc. quarterly revenues of $85.9B. McKesson Corp.'s net income of $1.3B is higher than Cencora, Inc.'s net income of $566.1M. Notably, McKesson Corp.'s price-to-earnings ratio is 27.25x while Cencora, Inc.'s PE ratio is 43.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson Corp. is 0.30x versus 0.22x for Cencora, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

CVS Health Corp. has a net margin of 1.18% compared to McKesson Corp.'s net margin of 2.77%. McKesson Corp.'s return on equity of -- beat CVS Health Corp.'s return on equity of 2.28%.

McKesson Corp. has a consensus price target of $980.40, signalling upside risk potential of 3.48%. On the other hand CVS Health Corp. has an analysts' consensus of $94.84 which suggests that it could grow by 23.67%. Given that CVS Health Corp. has higher upside potential than McKesson Corp., analysts believe CVS Health Corp. is more attractive than McKesson Corp..

McKesson Corp. has a beta of 0.405, which suggesting that the stock is 59.521% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.496, suggesting its less volatile than the S&P 500 by 50.368%.

McKesson Corp. has a quarterly dividend of $0.82 per share corresponding to a yield of 0.32%. CVS Health Corp. offers a yield of 3.47% to investors and pays a quarterly dividend of $0.67 per share. McKesson Corp. pays 10.69% of its earnings as a dividend. CVS Health Corp. pays out 191.23% of its earnings as a dividend. McKesson Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CVS Health Corp.'s is not.

McKesson Corp. quarterly revenues are $106.2B, which are larger than CVS Health Corp. quarterly revenues of $105.7B. McKesson Corp.'s net income of $1.3B is lower than CVS Health Corp.'s net income of $2.9B. Notably, McKesson Corp.'s price-to-earnings ratio is 27.25x while CVS Health Corp.'s PE ratio is 55.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson Corp. is 0.30x versus 0.24x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple, Inc. has a net margin of 1.18% compared to McKesson Corp.'s net margin of -184.62%. McKesson Corp.'s return on equity of -- beat Pineapple, Inc.'s return on equity of --.

McKesson Corp. has a consensus price target of $980.40, signalling upside risk potential of 3.48%. On the other hand Pineapple, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that McKesson Corp. has higher upside potential than Pineapple, Inc., analysts believe McKesson Corp. is more attractive than Pineapple, Inc..

McKesson Corp. has a beta of 0.405, which suggesting that the stock is 59.521% less volatile than S&P 500. In comparison Pineapple, Inc. has a beta of 41.097, suggesting its more volatile than the S&P 500 by 4009.732%.

McKesson Corp. has a quarterly dividend of $0.82 per share corresponding to a yield of 0.32%. Pineapple, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson Corp. pays 10.69% of its earnings as a dividend. Pineapple, Inc. pays out -- of its earnings as a dividend. McKesson Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson Corp. quarterly revenues are $106.2B, which are larger than Pineapple, Inc. quarterly revenues of $1.3K. McKesson Corp.'s net income of $1.3B is higher than Pineapple, Inc.'s net income of -$2.4K. Notably, McKesson Corp.'s price-to-earnings ratio is 27.25x while Pineapple, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson Corp. is 0.30x versus 50.83x for Pineapple, Inc.. Usually stocks with elevated PS ratios are considered overvalued.